tiprankstipranks
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market

Aerovate Therapeutics (AVTE) Technical Analysis

Compare
126 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Aerovate Therapeutics’s (AVTE) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Aerovate Therapeutics is a Sell.
Aerovate Therapeutics’s (AVTE) 20-Day exponential moving average is 2.46, while Aerovate Therapeutics’s (AVTE) share price is $2.4, making it a Sell.
Aerovate Therapeutics’s (AVTE) 50-Day exponential moving average is 2.51, while Aerovate Therapeutics’s (AVTE) share price is $2.4, making it a Sell.

Aerovate Therapeutics (AVTE) Pivot Points

Mar 04, 2025, 06:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.33
2.37
2.39
2.43
2.46
2.50
2.52
Fibonacci
2.37
2.39
2.41
2.43
2.46
2.47
2.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aerovate Therapeutics (AVTE) Moving Averages

Mar 04, 2025, 06:00 PM
Period
Simple
Exponential
MA5
2.42Buy
2.42Buy
MA10
2.41Buy
2.43Buy
MA20
2.47Sell
2.46Sell
MA50
2.53Sell
2.51Sell
MA100
2.50Sell
3.20Sell
MA200
4.30Sell
6.89Sell
Aerovate Therapeutics’s (AVTE) 10-Day exponential moving average is 2.43, while Aerovate Therapeutics’s (AVTE) share price is $2.4, making it a Buy.
Aerovate Therapeutics’s (AVTE) 100-Day exponential moving average is 3.20, while Aerovate Therapeutics’s (AVTE) share price is $2.4, making it a Sell.
Aerovate Therapeutics’s (AVTE) stock price is $2.4 and Aerovate Therapeutics’s (AVTE) 50-day simple moving average is 2.53, creating a Sell signal.
Aerovate Therapeutics’s (AVTE) stock price is $2.4 and Aerovate Therapeutics’s (AVTE) 100-day simple moving average is 2.50, creating a Sell signal.
Aerovate Therapeutics’s (AVTE) stock price is $2.4 and Aerovate Therapeutics’s (AVTE) 200-day simple moving average is 4.30, creating a Sell signal.

Aerovate Therapeutics (AVTE) Technical Indicators

Mar 04, 2025, 06:00 PM
Name
Value
Implied Action
RSI (14)
45.08
Neutral
STOCH (9,6)
50.88
Neutral
STOCHRSI (14)
37.97
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
20.85
Neutral
Williams %R
-47.37
Buy
CCI (14)
-47.80
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
37.32
Neutral
ROC
-1.62
Sell
Aerovate Therapeutics’s (AVTE) Relative Strength Index (RSI) is 45.08, creating a Neutral signal.
Aerovate Therapeutics’s (AVTE) Trend Strength Indicator (ADX) is 20.85, creating a Neutral signal.
Aerovate Therapeutics’s (AVTE) Commodity Channel Index (CCI) is -47.80, creating a Neutral signal.
Aerovate Therapeutics’s (AVTE) Price Rate of Change (ROC) is -1.62, creating a Sell signal.

FAQ

Is AVTE a Buy, Hold, or Sell?
Based on AVTE’s technical indicators, AVTE is a Sell.
    What is AVTE’s RSI (14)?
    AVTE’s RSI (14) is 45.08, which suggests AVTE is a Neutral.
      What is AVTE’s MACD?
      AVTE’s MACD is -0.04, which suggests AVTE is a Sell.
        What is AVTE’s 5-day moving average?
        AVTE’s 5-day moving average is 2.42, which suggests AVTE is a Buy.
          What is AVTE’s 20-day moving average?
          AVTE 20-day moving average is 2.47, which suggests AVTE is a Sell.
            What is AVTE’s 50-day moving average?
            AVTE’s 50-day moving average is 2.53, which suggests AVTE is a Sell.
              What is AVTE’s 200-day moving average?
              AVTE’s 200-day moving average is 4.30, which suggests AVTE is a Sell.
                What is AVTE’s Williams % R (14)?
                AVTE’s Williams % R (14) is -47.37, which suggests AVTE is a Buy.
                  What is AVTE’s CCI (14)?
                  AVTE’s CCI (14) is -47.80, which suggests AVTE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis